Pancreatic Transdisciplinary Cancer Team

group of people standing together in a hallway with some holding purple star balloons

The goal of the Pancreatic Transdisciplinary Cancer Team is to bring expertise from different disciplines in basic and clinical research to advance our understanding of pancreatic cancer and to translate that information to clinical trials to improve patient care in South Carolina.

The team consists of members with expertise in basic biology, oncology, pathology, surgery, population science, pharmacology, engineering, and informatics and biostatistics.

Co-Leaders

Team Members

Hollings Members

Tim Barnoud, Ph.D.
Hazel Breland, Ph.D.
Toros Dincman, M.D., Ph.D.
Nathan Dolloff, Ph.D.
Richard Drake, Ph.D.
Marvella Ford, Ph.D.
Saverio Gentile, Ph.D.
Mark Hamann, Ph.D.
William G. Hawkins, M.D.
Aaron Hobbs, Ph.D.
Brenda Hoffman, M.D.

Nancy Klauber-DeMore, M.D.
Craig Lockhart, M.D.
David Marshall, M.D.
John O’Bryan, Ph.D.
Besim Ogretmen, Ph.D.
Michael Ostrowski, Ph.D.
Sophie Paczesny, M.D., Ph.D.
Kevin K. Roggin, M.D.
Graham Warren, M.D., Ph.D.
Ozlem Yilmaz, D.D.S., Ph.D.

Non-Member Faculty

Badih Joseph Elmunzer, M.D.
Erin Forster, M.D.
David Lewin, M.D.
Robert Moran, M.D.
Katherine Morgan, M.D.

Daniel Reuben, M.D.
Reeder Robinson, Ph.D.
Sudarshana Sharma, Ph.D.
David Wang, M.D., Ph.D.
Hongjun Wang, Ph.D.

Trainees

Lucas Bialousow
Rachel Burge
Xiaoyan Chen, Ph.D.
Ben Christopher
Lu Han, Ph.D.
George Hanna
Nour Hijazi
Lillian Hsu, M.D.
Caroline Kittrell
Katie Marelia, Ph.D.
Dian Mayasari, Ph.D.
Megan Mazzei
Spencer Miller, Ph.D.

Moubashir Mintoo, Ph.D.
Roushney Mukti
Rakesh Nair, Ph.D.
Benjamin Pryce, Ph.D.
Colleen Quaas, Ph.D.
Krishna Ramajayam, Ph.D.
Lety Reyes
Ulyss (Karl) Roesner
Samaneh Saberikashani, Ph.D.
Devadoss Samuvel, Ph.D.
Kamala Sundararaj, Ph.D.
Nadia St. Thomas
Arash Velayati, M.D.

Patient Advocate

Jane Talbot

Staff

Elizabeth O’Quinn

2024 Presentation Schedule

January 9

“Dysregulation of PTEN Expression in a Subset of Cancer Associated Fibroblasts Promotes an Immune Suppressive Microenvironment in PDAC”

Ivo Woogeng, Ph.D.
Postdoc (Ostrowski Lab)
MUSC

February 13

“Novel Therapeutic Approaches for PDAC”

William Hawkins, M.D.
Professor, Surgery
MUSC

March 12

“Overview of Community Outreach and Engagement at Hollings Cancer Center and Opportunities for Collaboration”

Marvella Ford, Ph.D.
Associate Director, Population Science and Community Outreach and Engagement
Professor, Public Health Sciences
MUSC

April 16

“Review Highlights from AACR Conference, San Diego”

 

May 16

“Genomic Changes and Stromal Features Associated with Clinical Outcomes in Pancreatic Ductal Adenocarcinoma”

Toros Dincman, M.D., Ph.D.
Assistant Professor, Medicine
MUSC

June 11

“Best Practice for Translational and Clinical Investigators Using a Biorepository”

Angela Yoon, D.D.S.
Director, Biorepository and Tissue Analysis Shared Resource
Professor, Stomatology
MUSC

July 9

“Multimodal Spatial-omic Tissue Analysis of the Pancreatic Tumor, Stroma and Immune Microenvironment”

Richard Drake, Ph.D.
Professor, Cell and Molecular Pharmacology and Experimental Therapeutics
MUSC

August 13

“Enhancement of Mouse Models of PDAC”

David Wang, M.D., Ph.D.
Assistant Professor, Pediatrics
MUSC

September 10

“HSP70 in Cancer: New Functions and Therapeutic Opportunities”

Tim Barnoud, Ph.D.
Assistant Professor, Biochemistry and Molecular Biology
MUSC

October 8

“Review Highlights from AACR Pancreatic Cancer Conference, Boston”

 

November 21

“Talbot Pancreatic Cancer Awareness Reception”

 

December 10

“Protective Mechanisms in Pancreatic b-cells: From Antiviral to Antioxidants”

Jennifer Stancill, Ph.D.
Assistant Professor, Biochemistry and Molecular Biology
MUSC